Northern ‘zombies’ return to land of the living
The number of Northern businesses just paying the interest on their debts – a key characteristic of ‘zombie businesses’ – has plummeted from 45,000 in August 2014 to 10,000 now, …
Southport hotel sold after successful turnaround
A landmark Southport hotel has been sold to a Merseyside entrepreneur for a six-figure sum. The Bold Hotel on Lord Street has been acquired by AM Investments Ltd, which is …
Survey reflects new spirit of optimism in the North
Levels of distress amongst Northern businesses have fallen to below the national average, while an above average number are showing signs of growth, according to new research by insolvency trade …
Reforms ‘will improve trust in pre-packs’
Reforms to ‘pre-pack’ administrations have been welcomed by R3, the trade body for insolvency professionals. The changes include the introduction of an independent ‘pool’ of experts to review pre-pack sales …
New management team lead Bredbury Hall into new era
Bredbury Hall Hotel and Country Club, the iconic Stockport venue, has appointed a new management team as it begins a new chapter in its history. The historic hotel has also …
Entrepreneurs ‘must rethink their exit strategy’
Entrepreneurs could be holding back the growth of their business and jeopardising their long-term financial security by retaining full ownership of their company until retirement, according to Enterprise Ventures. It …
Interest rate rise would hurt 1 in 6 businesses
One in six businesses in the North of England (17 per cent) would face financial difficulty if interest rates rose by a percentage point or more, according to the latest …
Thousands of firms at risk in tax avoidance clampdown
Thousands of companies could be facing an uncertain future as a result of HMRC’s clampdown on tax avoidance schemes, according to the insolvency trade body R3. As HMRC steps up …
Evgen Pharma is 8th AIM listing for Enterprise Ventures
Evgen Pharma, which raised £7m through its successful flotation today, is the eighth company backed by Enterprise Ventures to become listed on the stock market. The Liverpool-based drug development company …